Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2023 Earnings Call Transcript August 8, 2023
Supernus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $0.23.
Operator: Good afternoon and welcome to Supernus Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, instructions will follow at that time. As a reminder,...
